Search for Clinical Trial Results
Malignant Germ Cell Tumor - 25 Studies Found
Status | Study |
Completed |
Study Name: Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors Condition:
Interventions: |
Completed |
Study Name: Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma Condition:
|
Recruiting |
Study Name: Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell Tumors Condition:
|
Active, not recruiting |
Study Name: Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor Condition:
|
Completed |
Study Name: Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas Condition:
|
Completed |
Study Name: Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment Condition:
Date: 2004-09-07 Interventions: Drug: oxaliplatin Given IV Other Names: |
Completed |
Study Name: Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas Condition:
Interventions: |
Recruiting |
Study Name: Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors Condition:
|
Completed |
Study Name: Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors Condition:
|
Completed |
Study Name: Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors Condition:
|